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Summary.-Data of 10,556 case-control pairs from the Oxford Survey of Childhood
Cancers and related sources have shown that when cancers originate in the reticulo-
endothelial system (RES neoplasms) they are liable to cause loss of immunological
competence before they are clinically recognizable. Since these early effects may have
lethal consequences, the true prevalence of RES neoplasms is difficult to identify,
especially in infection-sensitive age groups and populations with high death rates
from infection. An inevitable consequence of a nuclear holocaust is a high infection
death rate. Therefore, a population of A-bomb survivors is a totally unsuitable one
for studying the precise nature of the association between ionizing radiation and
human cancers.
WE can be reasonably certain that
cancers have long latent periods during
which abnormal cells that are no longer
under hormonal and other controls
(mutant or pre-cancer cells) will sooner or
later find an opportunity to begin multi-
plying at the expense of their normal
counterparts. Consequently, when cancers
originate in the reticulo-endothelial system
(RES neoplasms) they could be in a
position to cause considerable loss of
immunological competence before there
was any means of recognizing the true
state ofaffairs. Since this eventually would
be associated with difficulty in recognizing
the true frequency of these diseases in
infection-sensitive age groups (or the true
frequency of radiation-induced cancers
following a nuclear holocaust) we decided
to include in an extensive Mantel-
Haenszel analysis of data from the
Oxford Survey of Childhood Cancers
(OSCC) (Kneale and Stewart, 1976a, b,
1977) a test of the following null hypothe-
sis: "there is no increase in the prevalence
of non-fatal illnesses before the clinical
onset of a childhood cancer, and no
difference in this respect either between
children who eventually developed RES
neoplasms and solid tumours or between
secondary infections and other non-fatal
illnesses".
METHOD)S ANI) MATERIAL
Data sources-Most of the data for
testing this hypothesis were obtained directly
from mothers, who were usually interviewed
within 3 years of the single cancer death
affecting each case/control pair in the Oxford
Survey (Stewart and Barber, 1962). Each of
these pairs was formed by 2 children who
lived in the same locality and also had sex
and date of birth in common (original
matching factors) but in each pair there was
one child who had died of cancer before
15 years ofage during the period 1953 to 1970
(cancer case) and one child picked at random
from a local birth register (live control). For
these live and dead children there were
records ofall the illnesses from which they had
fully recovered before the mother of the
dead child had any reason to suspect the
fatal disease (as recollected by their mothers)
and for each of these "pre-onset illnesses"
there was usually a record of the interval
between recovery and the relevant caincer
death (pre-death period). Finally, the cancer
cases included 5778 RES neoplasms (ICD
Nos. 200-209) and 4778 solid tumours (ICD
Nos. 140-199) and the non-fatal diseases and
injuries were also coded according to the 8th
revision of the International ClassificationPRE-CANCERS AND LIABILITY TO OTHER DISEASES
(World Health Organization, 1967; see
Table III).
Method.-The only sources of information
about pre-onset illnesses were mothers of live
and dead children. Therefore, we were faced
with the possibility of biased reporting which,
even if it did not affect all the non-fatal ill-
nesses, would certainly affect some of the
illnesses with short pre-death periods since,
unless an accident had necessitated admission
to hospital or been rapidly followed by a fatal
cancer, it would probably be forgotten.
Therefore, it was necessary to have at least
one test ofthe null hypothesis which avoided
comparisons between live and dead children.
The cancer cases and their live controls
came from all parts of Britain and all walks
of life, and the death ages ofthe cancer cases
ranged from 0 to 15 years. Therefore, it was
essential to control for any effects of local
epidemics and final ages on total illness
TABLE I.-Mantel-Haenszel Analysis.
Specifications of Different Case and
Control Groups
Analysis
R/S
R/L
S/L
Cases
RES neoplasms
RES neoplasms
Solid tumours
Controls
Solid tumours
Live controls
Live controls
RES neoplasms ICD No. (8th Revision) 200-209.
Solid tumours ICD No. (8th Revision) 140-199;
210-239.
liability as well as for any effects of previous
illnesses on future illness liability. The
purpose of the test was also to discover
whether the notorious "infection-sensitivity"
of leukaemia patients was the result of
latent period changes. Therefore, it was
important to distinguish, not only between
cancers with and without direct involvement
of the immune system, but also between the
following groups of non-fatal illnesses: (i)
TABLEIJ. Mantel-Haenszel Analysis. Description ofTest and Controlling Factors
Test and controlling factorst
14 test factors or groups of pre-onset
illnesses
6 test factor levels or dates of the
pre-onset illnesses.
Extra controlling factors (with factor
levels in brackets).
Not included in the controlled analysis.
Specifications*
Primary infections 1. Measles
2. Chicken pox
3. Whooping cough
4. Mumps
5. Rubella
6. Scarlet fever
Primary and secondary infections 7. Bronchitis etc.
8. Tonsillitis etc.
9. Enteritis etc.
Auto-immune diseases 10. Allergies
Serious accidents 11. Fractures and Burns
Trivial complaints 12. Minor infections
13. Minor injuries
Residual illnesses 14. Miscellaneous
(0) 0-11
(1) 11-23
(2) 24-35 .months before the closing date.
(3) 36-47
(4) 48 or moreJ
(5) Never.
Birth cohort (in single years of birth)
Final age (in single years of age)
Undated illnesses.
Repeated attacks of the same or related illnesses.
Definitions:
Pre-onset: before there was any reason to suspect the fatal disease, or corresponding period for live
controls.
Closing date: date of death or corresponding date for live controls.
Final age: age at death or corresponding age of live controls.
Related illnesses: all those belonging to the same group of pre-onset illnesses.
* For detailed specifications of mixed illness groups see Table III.
t In each analysis, all test factors other than the one of immediate interest are automatically controlling
factors.
Note: Complications of primary infections (e.g. pneumonia following measles) were usually coded as
separate illnesses in the same period. But there was no coding of the commonest of all primary infections,
namely, the common cold.
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infections and other diseases or injuries; (ii)
primary infections (e.g. measles) and secon-
day infections (e.g. pneumonia); (iii) memor-
able and easily forgotten illnesses and (iv)
illnesses towards the beginning and end of
the variable periods at risk (so-called remote
and recent illnesses).
The method of choice was clearly a
Mantel-Haenszel analysis, since this would
allow 3 choices of test and control groups
(Table I) and several choices of test factors
(Table II). Also it would allow the test-
factor levels to be time periods related to the
events which distinguished sharply between
the live and dead children (i.e. the cancer
deaths). Therefore, it would be possible to
have one test of the null hypothesis which
was unaffected by different standards of
reporting bymothers oflive anddead children
(R/S analysis), and to have other tests which
would disclose the conditions most affected
by this potential source of bias (R/L and
S/L analyses).
By dividing the pre-onset illnesses into
14 diagnostic categories, and having as test-
factor levels 6 pre-death periods (including
"never") it was possible to distinguish
between: (i) infections and other pre-onset
illnesses; (ii) primary and secondary infec-
tions; (iii) memorable and easily forgotten
illness and (iv) remote and recent illnesses
(Table II). Also with 14 test factors and 6
test-factor levels there would be automatic
control of any effects of past illnesses in
future illness liability (Mantel and Haenszel,
1959). Therefore it would only need 2 "extra"
controlling factors, namely date of birth and
final age, to obtain full control of any effects
from local epidemics and final age.
In a Mantel-Haenszel analysis it is impera-
tive for all members of test and control
groups to be mentioned once and once only
in relation to each test factor. Therefore, it
was necessary for each group of unaffected
TABLE III.-Detailed Specifications of 8
TestFactors or Mixed Illness Groups. 8th
Revision ICD Nos. (Followed by Total
Number of Attacks in Sample)
7. Bronchitis etc. (3628)
466 (2606); 480 (937); 010 (40); 510-8 (27);
776 (18).
8. Tonsillitis etc. (3453)
463 (2670); 381 (591); 461 (110); 383 (46);
464 (36).
9. Enteritis etc. (1569)
001-9 (623); 541 (171); 070 (158); 683 (131);
323 (74); 075 (70); 684 (66); 595 (48); 040
(49); 136 (36); 079 (35); 590 (25); 053 (21);
720 (19); 038 (12); 567 (9); 032 (8); 731 (3);
84 (2); 035 (1).
10. Fractures and burns (1618)
N 800-29 (1012); N 940-9 (606).
11. Allergies (1339)
692 (567); 708 (438); 493 (294); 696 (31);
695 (9).
12. Minor infections (913)
680-2 (271); 470 (199); 360-9 (113); 057 (90);
110-12 (89); 784-5 (86); 129 (25); 605 (16);
722 (12); 622 (5); 133 (4); 565 (3).
13. Minor injuries (1755)
840-939 (1755).
14. Miscellaneous (618)
780 (309); 500 (123); 390-2 (60); 560 (39);
583 (29); N985 (15); 265 (12); 250-8
268 (7); 569 (7); 592 (5); 279 (4).
TABLE IV.-Crude Analysis (i). Pre-onset Illnesses of Cancer Cases and
Live Controls (All Attacks)
Single diseases
Mixed illness groups
Illnesses
1. Measles
2. Chicken pox
3. Whooping cough
4. Mumps
5. Rubella
6. Scarlet fever
7. Bronchitis etc.
8. Tonsillitis etc.
9. Enteritis etc.
10. Fractures and burns
11. Allergies
12. Minor infections
13. Minor injuries
14. Miscellaneous
All attacks
(A) (B) Live
Cancers controls
5173 5095
3214 3357
1770 1751
1666 1783
1442 1536
291 224
2081 1547
1939 1514
969 600
931 687
691 648
700 213
1386 369
385 233
A/B
1-02
0-96
1-10
0 93
0 94
1-30
1-35
1-28
1-62
1-36
1-07
3 00
3-76
1-64
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children to be included. So these children
were given a special position ("never") on the
test-factor-level scale. It was also necessary
for children who had more than one attack
of the same or closely related illnesses to be
represented by a single attack. Therefore,
since we were more interested in recent than
remote illnesses, we allowed "final attacks"
to take precedence over earlier attacks. For
example, any child with 2 attacks of measles
TABLE V.-Crude Analysis (ii). Case/Control Ratiosfor Pre-onset Illnesses in Stated
Pre-death Periods (Final Attacks)
Illnesses
Measles
Chicken pox
Whooping cough
Mumps
Rubella
Scarlet fever
Bronchitis etc.
Tonsillitis etc.
Enteritis etc.
Fractures and burns
Allergies
Minor infections
.Mnor injuries
Miscellaneous
Nos. of final attacks
Pre-death periods*
A
A - 5 Cancer Live
0 1 2 3 4 cases controls
1.0 1 0 1.1 1-1 1-0 5147 5074
09 0.9 1.0 1.0 1.0 3208 3353
1-2 1-0 0-8 1-1 1-0 1744 1741
1.0 09 09 1.0 0.9 1439 1523
0.9 0-8 1-2 0.9 1.0 1665 1783
0 9 0 7 1-4 1-5 1-4 232 188
1-7 1-5 1-3 1-2 1-2 1430 1115
2-3 1-2 1.1 1-3 1-0 806 545
2-8 1-7 1-4 1-2 1-3 1267 1108
1-5 1-4 1-4 1*4 1-2 820 626
1.1 1-5 1.1 1-2 1-0 616 586
5-2 3 9 1.9 4-7 2-0 579 205
7-2 3-4 3-3 2-9 2-9 1142 330
1*3 1-3 1-6 1-4 1-5 304 213
* See Table II.
TABLE VI.-R/S Analysis: Chi-squares for Overall Differences between RES
Neoplasms and Solid Tumours
Significant differences
Chi-
Illnesses squares*
Bronchitis etc. 26-4
Whooping cough 17-4
Fractures and burns 17-3
Tonsillitis etc. 15-0
Rubella 13-6
Enteritis etc. 11-8
Non-significant differences
Chi-
Illnesses squares*
Chicken pox
Minor infections
Mumps
Allergies
Minor injuries
Scarlet fever
Measles
Miscellaneous
9-1
8-2
7-4
6-6
6-1
3-5
3-5
3-5
* Significance levels for chi-squares (with 5 d.f.): 11-07: P = 0 05; 15-09: P = 0-01; 22-00: P = 0-001.
TABLE VII.-R/S Analysis: t values* for Differences between Observed and Expected
Illnesses in Stated Periods
Illnesses with significant
chi-squares (from
Table VI)
Bronchitis etc.
Whooping cough
Fractures and burns
Tonsillitis etc.
Rubella
Enteritis etc.
Test-factor levels or pre-death periods (as in Table II)
0
+4-2
+2 4
+2-9
+2-6
-1-5
+2-0
1
+0-6
-0-2
+2-2
+1-2
+1-9
+10
2 3
+2-0
+2-8
+1-3
-0-1
+0-2
+1-7
+1.9
+1-6
+1-3
+1-3
+2-8
-2-0
4
-0 5
+0-2
+0-2
+2-0
-0-6
+0-2
* Significance levels t = 2-0, P = 0 05 )
t = 2 6, P =001 + = observed illnesses more than expected.
t = 3-3, o.ooP- observed illnesses fewer than expected
5
-2-9
-2-7
-3-2
-3-4
-1-3
-1-3
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
-
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TABLE VIII.-R/L Analysis: Chi-squares for Overall Differences between
RES Neoplasms and Live Controls
Significant differences
r-
A
~~~Chi-
Illnesses
Minor injuries
Minor infections
Bronchitis etc.
Enteritis etc.
Tonsillitis etc.
Fractures and burns
Scarlet fever
Measles
squares*
369-7
161-6
66-6
57-1
53-8
41-6
13-0
11-7
Non-significant differences
A_
Illnesses
Allergies
Miscellaneous
Rubella
Chicken pox
Whooping cough
Mumps
* See Table VI footnote for significance levels.
was given the pre-death period of the second
attack and any child who had had repeated
attacks of bronchitis followed by pneumonia
was given the pre-death period of the final
illness.
The effects of converting all pre-onset
illnesses into final attacks of closely related
illnesses can be seen by comparing Tables IV
and V. These tables show the results of
straightforward comparisons between the
cancer cases and their matched controls
(crude analysis) and thus allow one to see
that, when the only controlling factors were
sex, date of birth and region, the case/control
ratios were much higher for minor accidents
and infections than for other illnesses; also
higher for the mixed groups of primary and
secondary infections than for the single
primary infections, and higher for recent
than for remote attacks. Thus, for the group
of minor injuries the case/control ratio was
3-8 for all attacks and 7-2 for final attacks
in the shortest pre-death period (under 1
year). For the largest groups of primary and
secondary infections (bronchitis etc.) the
corresponding figures were 1-4 and 1-7, and
for the largest group of primary infections
(measles) they were 1-0 and 1-0.
Fully controlled analysis.-In the Mantel-
Haenszel analysis the question whether any
of the illness groups were unevenly divided
between the test and the control groups was
settled by reference to the chi-squares in
Tables VI, VIII and X. Then, for each ofthe
illness groups which had recorded chi-squares
greater than 11-1 (with 5 degrees of freedom
this is significant at the 5% level) there were t
values for each test-factor level (Tables VII,
IX and XI) and a progressive component t
value (Table XII). The test-factor t values
showed which of the pre-death periods was
responsible for the overall difference, and the
progressive component t values carried
positive and negative signs which showed
whether the difference was increasing or
decreasing with progressive shortening of the
pre-death period (see footnote to Table XII,
also Mantel, 1963).
In theory the significant findings in these
tables could have 3 different origins: either
TABLE IX.-R/L Analysis: t Values* for Differences between Observed and Expected
Illnesses in Stated Periods
Illnesses with
significant
chi-squares
(from Table XIII)
Minor injuries
Minor infections
Bronchitis etc.
Enteritis etc.
Tonsillitis etc.
Fractures and burns
Scarlet fever
Measles
Test-factor levels or pre-death periods (as in Table II)
-
0
+ 11-1
+ 7-5
+5-7
+5-2
+6-2
+4-1
+0-9
+1-3
1
+6-8
+5 9
+2-9
+4-3
+2-0
+3-0
-0-2
-0-2
2
+8-4
+4-0
+2-9
+2-0
+0-4
+2-8
+2-0
+2-2
* Significance levels as in footnote to Table VII.
3 4
+5-9 +8-5
+5-6 +4-4
+2-1 +3-0
-0-5 +2-5
+2-6 +1-4
+1-6 +±19
+2-4 +1-6
+±15 +0-5
Chi-
squares*
10-2
9-6
8-0
6-4
4-0
1-8
5
-18-7
-12-0
-7-1
-5-9
-5-1
-5-7
-2-9
-2-8
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TABLE X.-S/L Analysis: Chi-squares for Overall Differences between Solid
Tumours and Live Controls
Significant differences
Chi-
Illnesses squares*
Minor injuries 367-9
Minor infections 99-9
Enteritis etc. 24-3
Tonsillitis etc. 15-6
Miscellaneous 12-7
Bronchitis etc. 12-4
Non-significant differences
, ~ ~ ~~AA
Chi-
Illnesses squares*
Measles 7-3
Rubella 7-0
Chicken pox 6-9
Whooping cough 6-2
Mumps 5-0
Allergies 3-9
Fractures and burns 2-9
* See Table VI footnote for significance levels.
TABLE XI.-S/L Analysis: t Values* for Differences between Observed and
Expected Illnesses in Stated Time Periods
Illnesses with
significant
chi-squares
(from Table X)
Minor injuries
Minor infections
Enteritis etc.
Tonsillitis etc.
Miscellaneous
Bronchitis etc.
Test-factor levels or pre-death periods (as in Table II)
0 1 2 3 4 5
+10-7
+5-7
+2-6
+3-4
+0-2
+1-1
+ 7-9
+5-3
+2-6
+0-7
-0-1
+2-4
+6-0
+1-7
+0-6
-0-6
+1-2
+0-2
+5-6
+4-4
+2-3
+0-9
+2-1
-0-9
+10-1
+4-0
+2-2
-1-6
+2-6
+2-2
* See Table VII footnote for significance levels.
TABLE XII.-Pre-onset Illness Risks:
Effects of Progressive Shortening of the
Pre-Death Period (t values in Mantel-
Haenszel Analysis)
Progressive components
_~~~~
Illnessesl
Bronchitis etc***
Tonsillitis etc***
Enteritis etc***
Whooping cough*
Fractures and
burns*
Rubella*
Measles
Scarlet fever
Minor infections
Minor injuries
Miscellaneous
Chicken pox
Mumps
Allergies
R/S
-4-3
-3-3
-2-1
-3-0
-4-1
-1-0
-0-6
0-9
-2-6
+0-2
-0-5
-2-6
-1-9
-2-2
R/L
-7-9
-6-4
-7-1
-1-5
-6-4
-1-7
-2-3
- 2-4
-12-1
-18-0
-2-2
-0-8
-0-1
-2-4
S/L
-2-5
-2-0
-4-5
+0-6
-1-5
+0-8
-1-1
-0-4
-9-2
-17-5
-1-8
+2-3
+1-1
+0-5
I*** Significant chi-squares in all 3 analyses.
* Significant chi-squares in the R/S analysis
only.
Italics: non-significant chi-squares in all 3 analyses.
- risk increasing with progressive shortening of
the pre-death period.
+ risk increasing with progressive lengthening
of the pre-death period.
(Significance levels as in footnote to Table VII.)
biased reporting of pre-onset illnesses by
mothers oflive and dead children; or some of
the non-fatal illnesses having delayed (car-
cinogenic) effects; or some of the cancers
having latent-period effects which had low-
ered resistance to other diseases. In practice,
the different origins would be associated with
different patterns ofsignificance. Forinstance,
any effects of biased reporting would not
affect the R/S analysis; and in the other
analyses minor illnesses in the shortest
period would be more affected than other
illnesses.
The second postulated effect would
probably have different effects on RES neo-
plasms and solid tumours, and might involve
viral infections more than other illnesses.
Also, since cancers have long latent periods
this effect should produce much higher t
values for remote than for recent attacks.
Finally, the third postulated effect would
certainly affect RES neoplasms more than
solid tumours, infections more than other
illnesses, secondary infections more than
primary ones, and recent more than remote
attacks. Therefore, there would be higher chi-
squares for the 3 illness groups which in-
-18-8
- 9-2
- 4-5
-0-4
-3-1
-2-7
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eluded secondary infections than the other
groups in the R/L than the S/L analysis. Also
the progressive component t values would be
indicative ofa mounting risk with progressive
shortening ofthe pre-death period, and (most
important) the R/S analysis would be affected
as well as the R/L analysis.
RESULTS
R/S analysis
The 3 illness groups which included
secondary infections had chi-squares
ranging from 26-4 to 11b8 (Table VI).
Only 3 of the remaining 11 groups had
similar findings, and they were whooping
cough (17.4) fractures and burns (17.3)
and rubella (13-6). For the 3 groups
representing secondary infections, the t
values for the shortest pre-death period
ranged from +4-2 to +2-0 (Table VII)
and the progressive component t values
from -4-3 to -2-1 (Table XII).
Therefore, in a fully controlled analysis
of 2 groups of dead children (RES neo-
plasms and solid tumours) the null hypo-
thesis was firmly rejected in favour of the
theory which expects any cancer with
direct involvement of the immune system
to begin undermining resistance to infec-
tions before it is clinically recognizable.
R/L analysis
There were exceptionally high chi-
squares for the groups of minor injuries
(369.7) and minor infections (161.6). Also,
the chi-squares for 3 mixed groups of
primary and secondary infections ranged
from 66-6 to 53'8 (Table VIII). In addition
there were significant chi-squares for
fractures and burns (41.6), scarlet fever
(13-0) and measles (11.7). For 5 illness
groups with exceptionally high chi-squares
(over 50.0), the t values for the shortest
pre-death period ranged from +11 1 to
+6-2 (Table IX) and the progressive
component t values from -180 to -6-4
(Table XII).
Therefore, in a fully controlled analysis
of a situation which allowed ample scope
for biased reporting by mothers of live
and dead children, there was definite
evidence of such an effect. The evidence
also suggests that mothers can easily
recall a trivial complaint if it is shortly
followed by a cancer death, but have
difficulty in recalling similar complaints
of healthy children.
S/L analysis
The chi-square for minor injuries (367.9)
was virtually the same as in the R/L
analysis, but the values for 4 mixed
groups of primary and secondary infec-
tions (including minor infections) though
statistically significant, were much lower
than the ones recorded in the R/L analysis
(Table X); and only one ofthe other illness
groups (miscellaneous) had a chi-square
>11 1. For the group of minor injuries,
and 3 of the infection groups the t values
for the shortest pre-death period ranged
from +10-7 to +2-6 (Table XI) and the
progressive component t values from
-17-5 to -2-5 (Table XII).
Taken in conjunction with the R/L
analysis, these findings are suggestive of
(i) under-reporting of minor injuries and
infections by mothers of live children, (ii)
equally good reporting ofhighly infectious
diseases by the mothers of live and dead
children and (iii) greater differences be-
tween RES neoplasms and live controls
TABLE XIII.-Illness Risks for RES Neoplasms in 5 Pre-death Periods Relative to Solid
Tumours (R/S) and Live Controls (R/L)
Pre-death periods
Under 12 months (0)
12-23 months (1)
24-35 months (2)
36-47 months (3)
Over 4 years (4)
Bronchitis etc.
r--A
R/S (R/L)
2-1 (2 5)
1.1 (1.6)
1*4 (1.5)
1*5 (1.5)
1.0 (1.3)
Tonsillitis etc.
R/S (R/L)
1-6
1-3
1.0
1-4
1-2
(2.6)
(1.4)
(1-1)
(1.6)
(1-1)
Enteritis etc.
A
R/S (R/L)
1.5 (3 0)
1-2 (2.2)
1*5 (1.5)
0-6 (0.9)
140 (1.3)
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than between solid tumours and live
controls in relation to recent attacks of
bronchitis, tonsillitis etc.
Illness risksfrom RES neoplasms relative to
solid tumours and live controls
The results of each Mantel-Haenszel
analysis included relative-risk estimates
for each test-factor level, some of which
are shown in Table XIII. For remote
attacks ofbronchitis, tonsillitis and gastro-
enteritis, there were negligible differences
between the test group (RES neoplasms)
and 2 control groups (cancer controls and
live controls) but for recent attacks (i.e.
within a year of the fatalities) the risk was
50-100% higher for the test group than
for the cancer controls, and 250-300o
higher for the test group than for the live
controls.
DISCUSSION
According to a fully controlled analysis
of data from an ongoing retrospective
survey of childhood cancers, there is
probably a period ofseveral months before
the clinical onset of certain childhood
cancers when infection risks are abnor-
mally high. This is probably due to
cancers of the immune system having
latent-period effects which either prevent
normal development of the affected cell
systems (exceptionally young cases) or
reduce the level of immunological compe-
tence (older cases).
It was only possible to compare the
illness risks ofchildren who later developed
RES neoplasms (test group) with children
who either developed solidtumours (cancer
controls) or were representative of normal
children (live controls). These compari-
sons showed that in relation to several
primary infections (which were also highly
infectious diseases, e.g. measles) there was
little or nothing to choose between the 3
groups of children. However, in relation to
3 mixed groups of primary and secondary
infections (which are only common among
infants and substandard children) there
were significant differences between the
TABLE XIV.-Estimated Effects of Two Components of the Pneumonia Risks of British
Children Born 1940-1950. Including Estimates of the Special Effects Associated with
Preleukaemia*
Starting After leukaemia After pneumonia After pneumonia Final state
population initiation infection death
never had pneumonia
* Sources: Kneale (1971), OSCC data, and official statistics of mortality.
30
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test group and both control groups,
differences which increased with pro-
gressive shortening of the pre-death
period.
Although the data were only suitable
for detecting the non-lethal component of
any infection risks associated with pre-
cancers, an earlier study, based partly on
the Oxford Survey and partly on official
statistics of mortality, demonstrated a
lethal component of the risk, and showed
that this was responsible for more pre-
leukaemia deaths before antibiotics were
discovered than in recent years (Kneale,
1971). By combining the 2 studies, we
have produced estimates of immediate
and delayed effects of both components,
and made them applicable to British
children born between 1940 and 1950
(Table XIV).
According to these estimates, unrecog-
nized leukaemias or latent-period deaths
ascribed to pneumonia were twice as
common as recognized cases, and for every
child who had recovered from an attack of
pneumonia before developing leukaemia
there were 7 or 8 children who died from
pneumonia during the terminal phase of
preleukaemia.
In the light of these observations, it is
hardly surprising that the discovery of
antibiotics was followed by an upsurge of
acute leukaemia deaths, followed by a
more gradual rise in the death rates for
other RES neoplasms. The extra cancer
deaths were first concentrated in countries
with high standards ofmedical care and in
infection-sensitive age groups (Hewitt,
1955) but eventually all countries experi-
enced similar changes, which gradually
brought the age distributions of their
leukaemia and lymphoma deaths into line
with the ones which have been recorded
in this country since 1968 (Stewart, 1972).
A single exception to the general rule
exists, inasmuch as there is no country
which has recorded a significant increase
in the number of myeloid-leukaemia
deaths within 5 years of birth. However,
this can be explained by assuming that,
when cancers combine near-conception
origins with rapid growth rates and
involvement of the immune system, they
may end by making a newborn child
totally dependent upon passive immunity
for survival. Consequently, latent-period
deaths might take the form of cot deaths
rather than infection deaths (Stewart,
1975, 1977).
Finally, according to the estimates in
Table XIV an attack ofpneumonia which
coincides with an advanced stage of pre-
leukaemia is at least 50 times as likely to
prove fatal as a "normal" attack. Conse-
quently, the OSCC-based estimates of the
cancer risks associated with foetal irradia-
tionwhichwere publishedin 1970 (Stewart
and Kneale) are only directly applicable
to children with similar infection risks.
This conclusion has important conse-
quences for survivors from the 1945 atomic
explosions, since aninevitable consequence
of any nuclear holocaust is an exception-
ally high infection-death rate for several
years after the event. These early deaths
are bound to have a disproportionate
effect on infection-sensitive individuals.
Therefore, it is clearly dangerous to use a
population of A-bomb survivors to study
the precise nature of the relationship
between ionizing radiation and human
cancers.
An example is a 10-year follow-up of
1250 A-bomb survivors (who were exposed
in utero to less than 500 rad) which only
succeeded in identifying one (non-leukae-
mic) cancer death. According to OSCC
estimates of risk the expected number of
radiogenic cancers was 20-0, and according
to national statistics the expected number
ofnon-radiogenic cancers was 0-82 (Jablon
and Kato, 1970). The wide discrepancy
between the first 2 numbers has often been
quoted as a reason for doubting the
validity of OSCC estimates. However,
unless human foetuses are totally in-
sensitive to the leukaemogenic effects of
radiation, there should have been some
cases of leukaemia among the A-bomb
survivors. Therefore, we can only suppose
that the proportion of unrecognized leu-
kaemias (due to latent-period abortions or
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deaths) was much higher in this popula-
tion than in the one covered by the Oxford
Survey.
The Oxford Survey data were collected by a
nation-wide network of doctors attached to County
and County Borough Health Departments. The
costs of the Mantel-Haenszel analysis were covered
by the United States Department of Health,
Education and Welfare (Contract Number 223-76-
6026 negotiated by the Bureau of Radiological
Health).
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